🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jade Biosciences, Inc.

JBIO Healthcare
$24.71 +$0.9 (3.78%)
Market Cap: $1.57 B
Gurus Holding
3
Popularity Rank
#3083
% of Shares Held
0.40%
Net Activity (Q2 2026)
-$3.23 M

Guru Ownership Trend

Guru Analysis for Jade Biosciences, Inc. (JBIO)

Jade Biosciences, Inc. (JBIO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.28 M.

Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.23 M net outflow during the quarter.

Recent activity highlights Cliff Asness who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 45.5%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$295,769
Total Buy Value
New Buys 1
Additions 0
-$3.52 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
1

FAQs for Jade Biosciences, Inc. (JBIO)

Major holders include Steven Cohen ($3.72 M), Renaissance Technologies (RenTech) ($1.64 M), Cliff Asness ($295,769). According to the latest reported data, 3 tracked investment managers collectively hold approximately 254,106 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.23 M, with 1 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited JBIO. The total reported sell value was $3.52 M.

Yes, 1 managers opened new positions in JBIO, and 0 increased their existing holdings. The total reported buy value was $295,769.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -36.7% 167,204 $3.72 M Q2 2026
0.00% Reduce -45.5% 73,591 $1.64 M Q2 2026
0.00% New Buy 13,311 $295,769 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form